Pipeline
PTS Indication
PTS302

Severe Malignant Airway Obstruction
PTS100

Hepatocellular Carcinoma
PTS-02

Adenoid cystic carcinoma
PTS500

Malignant pleural effusion
Pre-clinical phase
Clinical phase I
Clinical phase II
Clinical phase III
NDA Submission
Market Approval
 
 
 
 
 
 
 
New product
PTS037

New ingredient development
PTS040

New ingredient development
Pre-clinical phase
Clinical phase I
Clinical phase II
Clinical phase III
NDA Submission
Market Approval